194 related articles for article (PubMed ID: 33302212)
21. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
22. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
23. Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin.
Rahman WA; Habsa GH; Al-Mohrej OA; Hammad M; Selim NM; Hammad A
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020938865. PubMed ID: 32700655
[TBL] [Abstract][Full Text] [Related]
24. Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing.
Sindali K; Rose B; Soueid H; Jeer P; Saran D; Shrivastava R
Eur J Orthop Surg Traumatol; 2013 May; 23(4):481-6. PubMed ID: 23412293
[TBL] [Abstract][Full Text] [Related]
25. Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
Li XM; Sun SG; Zhang WD
Chin Med J (Engl); 2012 Jul; 125(13):2339-45. PubMed ID: 22882859
[TBL] [Abstract][Full Text] [Related]
26. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
[TBL] [Abstract][Full Text] [Related]
27. Association between metabolic syndrome and venous thromboembolism after total joint arthroplasty: a meta-analysis of cohort studies.
Yang Y; Li Z; Liang H; Tian J
J Orthop Surg Res; 2020 Nov; 15(1):570. PubMed ID: 33256765
[TBL] [Abstract][Full Text] [Related]
28. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of 11 anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and network meta-analysis.
Huang Z; Xu X; Xu D; Zhao P; Zou M
Medicine (Baltimore); 2023 Jan; 102(2):e32635. PubMed ID: 36637921
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy and safety of fondaparinux versus enoxaparin for preventing venous thromboembolism after major orthopedic surgery: a meta-analysis].
Li H; Wang J; Xiao J; Shi Z
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Mar; 33(3):370-5. PubMed ID: 23529234
[TBL] [Abstract][Full Text] [Related]
31. High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.
Groot OQ; Ogink PT; Paulino Pereira NR; Ferrone ML; Harris MB; Lozano-Calderon SA; Schoenfeld AJ; Schwab JH
Clin Orthop Relat Res; 2019 Jul; 477(7):1674-1686. PubMed ID: 31135550
[TBL] [Abstract][Full Text] [Related]
32. Do We Need Chemoprophylaxis to Prevent Venous Thromboembolism following Medial Open-Wedge High Tibial Osteotomy?
Kim KI; Kim GB; Lee MG; Song SJ
J Knee Surg; 2021 Jul; 34(9):1007-1013. PubMed ID: 31931550
[TBL] [Abstract][Full Text] [Related]
33. Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
Millar JS; Lawes CM; Farrington B; Andrew P; Misur P; Merriman E; Walker M
N Z Med J; 2020 Mar; 133(1511):52-60. PubMed ID: 32161421
[TBL] [Abstract][Full Text] [Related]
34. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
Nieto JA; Espada NG; Merino RG; González TC
Thromb Res; 2012 Aug; 130(2):183-91. PubMed ID: 22425218
[TBL] [Abstract][Full Text] [Related]
35. The necessity of pharmacological prophylaxis against venous thromboembolism in major joint arthroplasty.
Yassin M; Mitchell C; Diab M; Senior C
Int Orthop; 2014 May; 38(5):1073-5. PubMed ID: 24352825
[TBL] [Abstract][Full Text] [Related]
36. Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal.
Holmes M; Carroll C; Papaioannou D
Health Technol Assess; 2009 Sep; 13 Suppl 2():55-62. PubMed ID: 19804690
[TBL] [Abstract][Full Text] [Related]
37. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
38. Safety and Efficacy of New Anticoagulants for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty: A Meta-Analysis.
Venker BT; Ganti BR; Lin H; Lee ED; Nunley RM; Gage BF
J Arthroplasty; 2017 Feb; 32(2):645-652. PubMed ID: 27823844
[TBL] [Abstract][Full Text] [Related]
39. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Turpie AG; Bauer KA; Eriksson BI; Lassen MR
Arch Intern Med; 2002 Sep; 162(16):1833-40. PubMed ID: 12196081
[TBL] [Abstract][Full Text] [Related]
40. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
Herlihy DR; Thomas M; Tran QH; Puttaswamy V
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD010525. PubMed ID: 32692430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]